.jpg)
TSH's new combo new drug has been approved and expect to get NHI price in Q2,2022. Its potentional market is approximately 2.8
2021.10.20
...
TSH Biopharm was invited to attend the online institutional investor conference hosted by IBF Securities
2021.9.27
...
.jpg)
The Company's 2021 annual general meeting approved removal of the noncompetition restrictions for directors
2021.8.20
...
.jpg)
.jpg)
The Board of Directors resolved to change the date and location of 2021 Annual Shareholders’ Meeting
2021.8.3
...
